Objective quantification of arm rigidity in MPTP-treated primates

Rigidity is a cardinal symptom of Parkinson's disease and is frequently used as an outcome measure in clinical and non-human primate studies examining the effects of medication or surgical intervention. A limitation of current rigidity assessment methods is that they are inherently subjective. To better understand the physiological mechanisms of rigidity and how various therapeutic approaches work, a more objective and quantitative method is needed. In this study, an automated arm rigidity testing (ART) system was developed to objectively quantify rigidity while the primate's limb was moved between two user-specified angles. Recordings of normal force versus elbow-angle were categorized according to area and slope. These quantitative measures of rigidity were investigated in three rhesus macaque monkeys treated with 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine and compared with clinical assessment methods. The ART system incorporates electromyographical recordings that can detect and differentiate active from actual resistance. The ART system detected significant changes in rigidity measures following administration of apomorphine or deep brain stimulation of the globus pallidus internus. The most sensitive measures were total area, extension slope, and flexion slope. The ART system provides precise and reliable measures of rigidity that are objective and quantitative.

[1]  A Eschalier,et al.  Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP , 2001, Journal of Neuroscience Methods.

[2]  I. Hwang,et al.  Quantitative analysis of the velocity related pathophysiology of spasticity and rigidity in the elbow flexors , 2002, Journal of neurology, neurosurgery, and psychiatry.

[3]  Jack J. Chen,et al.  A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease. , 2005, Clinical therapeutics.

[4]  Behrooz Sepehri,et al.  Quantification of Rigidity in Parkinson’s Disease , 2007, Annals of Biomedical Engineering.

[5]  J. Vitek,et al.  Stimulation of the Subthalamic Nucleus Changes the Firing Pattern of Pallidal Neurons , 2003, The Journal of Neuroscience.

[6]  M. Caligiuri,et al.  Portable device for quantifying parkinsonian wrist rigidity , 1994, Movement disorders : official journal of the Movement Disorder Society.

[7]  Margaret K.Y. Mak,et al.  Quantitative measurement of trunk rigidity in parkinsonian patients , 2007, Journal of Neurology.

[8]  D. Backus.  Measurement of Rigidity in Parkinsonʼs Disease , 1997 .

[9]  J. McAuley,et al.  The physiological basis of clinical deficits in Parkinson’s disease , 2003, Progress in Neurobiology.

[10]  R Patterson,et al.  Muscular hypertonia: quantitative analysis. , 1979, Archives of physical medicine and rehabilitation.

[11]  K. Black,et al.  MPTP induces dystonia and parkinsonism , 1997, Neurology.

[12]  Academisch Proefschrift,et al.  UvA-DARE ( Digital Academic Repository ) Clinimetrics , clinical profile and prognosis in early Parkinson ’ s disease , 2009 .

[13]  J. Villemure,et al.  How do parkinsonian signs return after discontinuation of subthalamic DBS? , 2003, Neurology.

[14]  F. Walshe,et al.  OBSERVATIONS ON THE NATURE OF THE MUSCULAR RIGIDITY OF PARALYSIS AGITANS, AND ON ITS RELATIONSHIP TO TREMOR , 1924 .

[15]  W. Z. Rymer,et al.  A comparison of the effects of imposed extension and flexion movements on Parkinsonian rigidity , 2006, Clinical Neurophysiology.

[16]  E. Bézard,et al.  Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey , 2000, Journal of Neuroscience Methods.

[17]  P. LeWitt.  Subcutaneously administered apomorphine , 2004, Neurology.

[18]  W. Rymer,et al.  The role of shortening reaction in mediating rigidity in Parkinson’s disease , 2004, Experimental Brain Research.

[19]  M. Pinter,et al.  Quantification of motor deficit in Parkinson's disease with a motor performance test series , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[20]  A. Prochazka,et al.  Quantification of the UPDRS rigidity scale , 2001, IEEE Transactions on Neural Systems and Rehabilitation Engineering.

[21]  D. Jacobowitz,et al.  Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1986, Life sciences.